Dr Miele Cosmed Group (WAR:DMG) Beneish M-Score: -2.56 (As of Jun. 26, 2026)


WAR:DMG Dr Miele Cosmed Group SA WAR:DMG
70 GF Score
Price zł2.31
GF Value zł3.84
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dr Miele Cosmed Group Beneish M-Score?

Dr Miele Cosmed Group WAR:DMG 70 Beneish M-Score is -2.56 as of Jun. 26, 2026. GuruFocus rates WAR:DMG with a GF Score™ of 70/100 and a GF Value™ of zł3.84 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,849 Consumer Packaged Goods companies, Dr Miele Cosmed Group ranks better than 53.38% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.56 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Dr Miele Cosmed Group's Beneish M-Score or its related term are showing as below:

WAR:DMG' s Beneish M-Score Range Over the Past 10 Years
Min: -4.19   Med: -2.55   Max: 8.62
Current: -2.56

During the past 13 years, the highest Beneish M-Score of Dr Miele Cosmed Group was 8.62. The lowest was -4.19. And the median was -2.55.


Dr Miele Cosmed Group Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Dr Miele Cosmed Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Miele Cosmed Group Beneish M-Score Chart

Dr Miele Cosmed Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.55 -2.54 -2.57 -2.73 -2.56

Dr Miele Cosmed Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.56 0.00

WAR:DMG vs PG, CL, KVUE: Beneish M-Score Comparison

For the Household & Personal Products subindustry, Dr Miele Cosmed Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Miele Cosmed Group Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Miele Cosmed Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Dr Miele Cosmed Group's Beneish M-Score falls into.


WAR:DMG
70GF Score
Dr Miele Cosmed Group SA WAR:DMG
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Miele Cosmed Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Dr Miele Cosmed Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1215+0.528 * 1.0162+0.404 * 0.9647+0.892 * 1.0325+0.115 * 1.0013
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.045666-0.327 * 0.991
=-2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was zł50.9 Mil.
Revenue was zł504.2 Mil.
Gross Profit was zł212.8 Mil.
Total Current Assets was zł123.7 Mil.
Total Assets was zł425.8 Mil.
Property, Plant and Equipment(Net PPE) was zł171.8 Mil.
Depreciation, Depletion and Amortization(DDA) was zł14.4 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.0 Mil.
Total Current Liabilities was zł127.3 Mil.
Long-Term Debt & Capital Lease Obligation was zł10.1 Mil.
Net Income was zł19.7 Mil.
Gross Profit was zł0.0 Mil.
Cash Flow from Operations was zł39.1 Mil.
Total Receivables was zł43.9 Mil.
Revenue was zł488.4 Mil.
Gross Profit was zł209.5 Mil.
Total Current Assets was zł127.1 Mil.
Total Assets was zł404.8 Mil.
Property, Plant and Equipment(Net PPE) was zł149.2 Mil.
Depreciation, Depletion and Amortization(DDA) was zł12.6 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.0 Mil.
Total Current Liabilities was zł120.0 Mil.
Long-Term Debt & Capital Lease Obligation was zł11.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(50.85 / 504.213) / (43.916 / 488.352)
=0.10085 / 0.089927
=1.1215

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(209.453 / 488.352) / (212.803 / 504.213)
=0.428898 / 0.42205
=1.0162

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (123.678 + 171.791) / 425.827) / (1 - (127.136 + 149.233) / 404.839)
=0.306129 / 0.317336
=0.9647

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=504.213 / 488.352
=1.0325

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(12.56 / (12.56 + 149.233)) / (14.439 / (14.439 + 171.791))
=0.07763 / 0.077533
=1.0013

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 504.213) / (0 / 488.352)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10.071 + 127.313) / 425.827) / ((11.768 + 120.037) / 404.839)
=0.322629 / 0.325574
=0.991

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(19.693 - 0 - 39.139) / 425.827
=-0.045666

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Dr Miele Cosmed Group has a M-score of -2.56 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.56 mean?
Dr Miele Cosmed Group (WAR:DMG) has a Beneish M-Score of -2.56 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dr Miele Cosmed Group and its competitors. According to the industry distribution chart, Dr Miele Cosmed Group ranks #862 out of 1849 companies in the Consumer Packaged Goods industry, placing it in the top 46.6%.
Is Dr Miele Cosmed Group's Beneish M-Score too high?
Dr Miele Cosmed Group's current Beneish M-Score is -2.56. Based on the distribution chart, Dr Miele Cosmed Group ranks #862 out of 1849 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Dr Miele Cosmed Group has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Miele Cosmed Group's Beneish M-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Miele Cosmed Group ranks #862 out of 1849 companies for Beneish M-Score. This puts Dr Miele Cosmed Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dr Miele Cosmed Group and its competitors. Dr Miele Cosmed Group's current Beneish M-Score is -2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Miele Cosmed Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Miele Cosmed Group (WAR:DMG) is currently considered Significantly Undervalued. The stock's GF Value™ is zł3.84, compared to a current price of zł2.31 — trading 39.8% below its estimated fair value. The current Beneish M-Score is -2.56. Dr Miele Cosmed Group's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Dr Miele Cosmed Group (WAR:DMG), the current Beneish M-Score is -2.56 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Miele Cosmed Group (WAR:DMG) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Miele Cosmed Group stock appears to be undervalued. The current stock price of zł2.31 is trading 39.8% below its estimated GF Value™ of zł3.84. GuruFocus considers Dr Miele Cosmed Group to be Significantly Undervalued.

Key valuation signals for WAR:DMG:

  • Beneish M-Score: -2.56
  • GF Value™: zł3.84 vs. price of zł2.31 (39.8% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the WAR:DMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Miele Cosmed Group Business Description

Address Ulica Wielkopolska 3, Radom, POL, 26-600
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
70GF Score

Get the complete analysis for WAR:DMG

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.31
Price
zł3.84
GF Value